rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Barry Shin

CFO

Company insider

Files Form 4 as: CFO, Compass Therapeutics; Acting COO and CFO, Trevena.

In numbers

Trades disclosed
39
Buys
0
Sells
1
Bought
$0
Sold
$13K
Companies
2
Companies where not an officer
0
First trade
25 Jun 2019
Last trade
2 Jan 2026
Last filed
5 Jan 2026

Companies traded

Where they are an officer
CMPX Compass TherapeuticsOfficer · Biotechnology · last 2 Jan 20260 buys · 0 sells
TrevenaOfficer · last 8 Oct 20240 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
2 Jan 2026filed 5 Jan 2026CMPX Compass TherapeuticsBiotechnologySEC FORM 4 Code A$646K125,000 at $5.17filing
2 Jan 2026filed 5 Jan 2026CMPX Compass Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—670,000 at $0.00filing
2 Jan 2026filed 5 Jan 2026CMPX Compass Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—670,000 at $0.00filing
2 Jan 2026filed 5 Jan 2026CMPX Compass TherapeuticsBiotechnologySEC FORM 4 Code A$646K125,000 at $5.17filing
11 Feb 2025filed 13 Feb 2025CMPX Compass Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—250,000 at $0.00filing
9 Dec 2024filed 10 Dec 2024CMPX Compass Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—400,000 at $0.00filing
9 Dec 2024filed 10 Dec 2024CMPX Compass TherapeuticsBiotechnologySEC FORM 4 Code A$660K400,000 at $1.65filing
8 Oct 2024filed 10 Oct 2024TrevenaSEC FORM 4 Code F$2517 at $1.47filing
8 Oct 2024filed 10 Oct 2024TrevenaSEC FORM 4 Code F$6041 at $1.47filing
8 Oct 2024filed 10 Oct 2024TrevenaSEC FORM 4 Code F$191130 at $1.47filing
8 Oct 2024filed 10 Oct 2024TrevenaSEC FORM 4 Code F$191130 at $1.47filing
8 Oct 2024filed 10 Oct 2024TrevenaSEC FORM 4 Code F$717488 at $1.47filing
14 Sep 2024filed 17 Sep 2024TrevenaSEC FORM 4 Code F$183 at $5.95filing
14 Dec 2023filed 15 Dec 2023TrevenaSEC FORM 4 Code A$113K185,000 at $0.61filing
14 Dec 2023filed 15 Dec 2023TrevenaSEC FORM 4 Code A$31K50,000 at $0.61filing
14 Dec 2023filed 15 Dec 2023TrevenaSEC FORM 4 Code F$2,2063,616 at $0.61filing
2 Dec 2023filed 5 Dec 2023TrevenaSEC FORM 4 Code F$240407 at $0.59filing
2 Dec 2023filed 5 Dec 2023TrevenaSEC FORM 4 Code F$6041,023 at $0.59filing
2 Dec 2023filed 5 Dec 2023TrevenaSEC FORM 4 Code F$2,1283,606 at $0.59filing
14 Sep 2023filed 18 Sep 2023TrevenaSEC FORM 4 Code F$5072 at $0.70filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Neil LernerChief Accounting Officer · Chief Accounting Officer at Compass Therapeutics, filing Form 4 there in the last year
Jonathan AndermanGeneral Counsel · General Counsel at Compass Therapeutics, filing Form 4 there in the last year
Thomas J. SchuetzChief Executive Officer · Chief Executive Officer at Compass Therapeutics, filing Form 4 there in the last year
Ellen ChiniaraDirector · Director at Compass Therapeutics, filing Form 4 there in the last year
Cynthia SirardChief Medical Officer · Chief Medical Officer at Compass Therapeutics, filing Form 4 there in the last year